Moderna rStock
RMRNA #1587Project Safety Score: 15%
Updated 14 hours, 53 minutes ago& Market
Credibility
Behavioral
Mechanics
Distribution
Moderna engages in the research, development, and manufacturing of prescription drugs for infectious diseases and other conditions. Its products and candidate pipelines are entirely based on its messenger RNA (mRNA) technology platform. The business covers preclinical molecular design, advancement of human clinical trials, and scaled production of vaccines. The company primarily supplies approved biological products and related vaccines to national governments and healthcare institutions.
Risk Report
Cryptocurrency carries risk. Every project listed on this site, regardless of its score, operates in a volatile and largely unregulated market. Tokens can lose most or all of their value. A high score reflects lower structural risk based on the data we can measure. It does not mean a project is safe, that the price will hold, or that losses are unlikely. Always research independently and never commit money you cannot afford to lose.
Price Chart - Moderna rStock
View on Chain
Technical Analysis
Buy / Sell signals